ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1139

Molecular Pathways Identified from Risk Alleles Identify Mechanistic Differences in Systemic Lupus Erythematosus Patients of East Asian and European Ancestry

Katherine Owen1, Kristy Bell2, Andrew Price3, Prathyusha Bachali4, Hannah Ainsworth5, Miranda Marion6, Timothy Howard5, Carl Langefeld7, Nan Shen8, Jinoos Yazdany9, Maria Dall'Era10, Amrie Grammer11 and Peter Lipsky3, 1RILITE, Crozet, VA, 2AMPEL BioSolutions LLC, Charlottesville, VA, 3AMPEL BioSolutions, Charlottesville, VA, 4AMPEL BioSolutions, Redmond, WA, 5Wake Forest School of Medicine, Winston-Salem, NC, 6Wake Forest University, Winston-Salem, NC, 7Wake Forest School of Medicine, Winston Salem, NC, 8Shanghai Jiang Tong University School of Medicine, Shanghai, China, 9UCSF, San Francisco, CA, 10University of California, Division of Rheumatology, San Francisco, CA, 11AMPEL LLC, Charlottesville, VA

Meeting: ACR Convergence 2022

Keywords: Bioinformatics, Gene Expression, genetics, Systemic lupus erythematosus (SLE), Systems-based Studies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Genetics, Genomics and Proteomics Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: SLE is a multi-organ autoimmune disorder with a prominent genetic component. Individuals of Asian-Ancestry (AsA) disproportionately experience more severe SLE compared to individuals of European-Ancestry (EA), including increased kidney involvement and tissue damage. Whereas some of this variation may be accounted for by environmental and/or socioeconomic factors, the possibility that risk alleles differentially expressed within patients of AsA ancestry influence the molecular mechanisms involved in SLE pathogenesis and contribute to enhanced clinical severity has not been explored.

Methods: SLE Immunochip-based association studies identified single nucleotide polymorphisms (SNPs) significantly associated with SLE in EA (6748 cases; 11516 controls) and AsA (2485 cases and 3947 controls from Koreans (KR), Han Chinese (HC) and Malaysian Chinese (MC)). To map causal SNPs to genes, we leveraged the relationship between SNPs and genes in coding regions (C-SNP), eQTL status (E-SNP), transcription factors (T-SNP), and proximity (P-SNP). Protein-protein interaction networks were generated by STRING, visualized in Cytoscape, partitioned with MCODE and annotated using Biologically Informed Gene Clustering (BIG-C), Immune (I)-Scope, Ingenuity Pathway Analysis (IPA) and EnrichR. Gene set variation analysis (GSVA) was used to estimate the variation of pre-defined informative gene sets in patient and control samples of gene expression datasets.

Results: We identified 3,066 ancestry-specific and 384 trans-ancestry SNP-linked genes associated with SLE. Genetic associations were examined using connectivity mapping, and gene signatures based on predicted biological pathways were used to interrogate gene expression datasets. SLE-associated pathways in AsA patients included elevated oxidative stress, altered metabolism and mitochondrial dysfunction, whereas SLE-associated pathways in EA patients included a robust interferon response (type I and II) related to enhanced cytosolic nucleic acid sensing and signaling (Figure 1). An independent dataset derived from summary genome-wide association data in an AsA cohort identified similar molecular pathways. Gene expression data from AsA SLE patients corroborated the molecular pathways and dominant cell types predicted by SNP associations.

Conclusion: The SNP-associated predicted genes and gene expression profiles outlined here implicate similarities and also fundamental differences in lupus molecular pathways operative in EA and AsA ancestral populations. Our findings indicate that certain pathways may be enriched in one ancestral population over another, but those pathways may not be active within every patient of a given ancestry and may be active in patients from other ancestries. Systems bioinformatics and assessment using gene signature enrichment analyses revealed alterations in cellular metabolism and cell stress signatures that may be more prevalent in patients of Asian ancestry. Identifying molecular pathways predicted by ancestry specific genetic SLE risk analyses may help to disentangle the population differences in clinical severity that impact AsA and EA individuals with SLE and guide targeted therapies (Figure 1).

Supporting image 1

Figure 1. Summary of lupus molecular pathways, dominant cell types and potential treatment options in EA and AsA ancestral populations.


Disclosures: K. Owen, None; K. Bell, None; A. Price, None; P. Bachali, None; H. Ainsworth, None; M. Marion, None; T. Howard, None; C. Langefeld, None; N. Shen, None; J. Yazdany, AstraZeneca, Gilead, Bristol-Myers Squibb(BMS), Aurinia, Astra Zeneca, Pfizer; M. Dall'Era, GlaxoSmithKline (GSK), AstraZeneca, Aurinia, BMS, Amgen; A. Grammer, None; P. Lipsky, None.

To cite this abstract in AMA style:

Owen K, Bell K, Price A, Bachali P, Ainsworth H, Marion M, Howard T, Langefeld C, Shen N, Yazdany J, Dall'Era M, Grammer A, Lipsky P. Molecular Pathways Identified from Risk Alleles Identify Mechanistic Differences in Systemic Lupus Erythematosus Patients of East Asian and European Ancestry [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/molecular-pathways-identified-from-risk-alleles-identify-mechanistic-differences-in-systemic-lupus-erythematosus-patients-of-east-asian-and-european-ancestry/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/molecular-pathways-identified-from-risk-alleles-identify-mechanistic-differences-in-systemic-lupus-erythematosus-patients-of-east-asian-and-european-ancestry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology